IPO News
Upcoming and recent IPOs, SPAC mergers, and direct listings. Track new stock market listings, IPO pricing, and first-day trading performance.
X-Energy's IPO Surge Faces Reality Check Amid Nuclear Ambitions
X-Energy shares rose 33% from IPO price to $30.53, but fell from weekly highs. Kentucky utilities explore its Xe-100 reactor as the company tackles licensing and construction challenges.
Sivers Semiconductors Faces Tight Timeline for Nasdaq Listing and Share Vote
Sivers Semiconductors faces a May 11 vote on a 125 million crown share issue and a delayed annual report as it pursues a Nasdaq New York dual listing.
Pershing Square IPO Package Returns to Profit After Volatile Start
Pershing Square Inc. shares rose to $37.99, lifting the combined IPO package above the $50 offer price after a volatile NYSE debut.
UTime Seeks to Withdraw Resale Registration, Shares Surge
UTime Limited (WTO) shares rose 8.36% after the company asked the SEC to withdraw a resale registration statement that was never declared effective.
Rare Earths Americas IPO Targets $368M Valuation Amid China Supply Concerns
Rare Earths Americas began its U.S. IPO roadshow, aiming for a valuation up to $368.4 million and planning to raise as much as $52.8 million by selling shares at $17–$19 each.
Brazil's IPO Market Eyes Revival with Cosan's $5.1B Compass Listing
Cosan SA is moving forward with a secondary offering of Compass Gás e Energia shares, targeting up to R$5.1 billion to reduce debt, potentially reviving Brazil's IPO market.
Oruka Therapeutics Soars on Psoriasis Drug Data, Announces $500M Offering
Oruka Therapeutics shares surged after interim data showed its psoriasis drug ORKA-001 achieved 63.5% complete skin clearance. The company also announced a $500M public offering.
Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial
Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.
Rocket Lab Shares Dip as SpaceX IPO Buzz and Earnings Loom
Rocket Lab shares slipped 2.3% as investors await Q1 earnings due May 7, with SpaceX's IPO intensifying scrutiny of space-sector valuations.
SpaceX IPO: Starlink and Starship at Forefront as $1.75 Trillion Valuation Looms
SpaceX's confidential IPO filing targets a $1.75 trillion valuation, with Starlink's cash generation and Starship's advancements key to investor appeal.
Horizon Quantum Faces Supply Test After 53M-Share Resale Filing
Horizon Quantum Holdings filed to register the resale of nearly 53 million shares, representing 91.9% of outstanding stock, just weeks after its Nasdaq debut.
Xanadu Stock Surges 7% on 294M Share Resale Filing
Xanadu Quantum Technologies shares climbed 7.28% to $30.95 following a registration statement for up to 293.7 million Class B shares. The filing does not represent new capital for the company.